|Mr. Douglas Glen Janzen||Chairman, CEO & Pres||180k||N/A||1969|
|Ms. Ann Fehr CGA, CPA||Chief Financial Officer||96.56k||N/A||1969|
|Ms. Anne Michelle Stevens BSc, MHA||COO, Corp. Sec. & Director||141.8k||N/A||1981|
|Mr. Ian Richard Ball||Chief Commercial Officer||144k||N/A||N/A|
|Dr. Donald Alan McAfee||Chief Scientific Officer||N/A||N/A||1942|
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistita, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Zepto, a precision pulse capsulotomy system that provides anterior lens capsulotomies during cataract surgeries; and Tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejection following organ transplantation. It also offers Topiramate XR and Oxcarbazepine XR extended-release oral tablets for the treatment of epilepsy. In addition, the company's development stage product includes AQS1301, a transdermal formulation of aripiprazole for the treatment of bipolar I disorders, schizophrenia, and depressive disorders; AQS1303, a transdermal pyridoxine/doxylamine for the treatment of nausea and vomiting of pregnancy; and AQS1304, a cannabinoid-based therapeutics for neurological disorders. The company has collaboration agreements with Sandoz Canada, Inc. for the promotion of Vistitan; Supernus Pharmaceuticals, Inc. for marketing of extended-release anti-epileptic drugs; Mynosys Cellular Devices for distribution, sales and marketing of Zepto for cataract surgery; and Medicom Healthcare Ltd. to focus on preservative free therapies in ophthalmology. Aequus Pharmaceuticals Inc. was founded in 2013 and is headquartered in Vancouver, Canada.
Aequus Pharmaceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.